Literature DB >> 12010386

Prevalences of migraine and tension-type headache in adolescent girls of Shiraz (southern Iran).

S M T Ayatollahi1, F Moradi, S A R Ayatollahi.   

Abstract

OBJECTIVE: To determine the prevalences of migraine and tension-type headache in teenaged girls attending schools in Shiraz (southern Iran).
BACKGROUND: Studies of headache prevalence are numerous, and findings have varied according to the specific population and region involved. No data are available regarding headache prevalence among Iranian teenagers.
METHODS: A random sample of 1868 teenaged girls (aged 11 to 18 years) was evaluated, and 507 subjects reported headache. The headache disorders were classified on the basis of a clinical interview, general physical and neurologic examinations, and the diagnostic criteria of the International Headache Society. Logistic regression was used for data analysis.
RESULTS: Overall prevalence rate for migraine was 6.1% (95% CI, 5.0 to 7.2) and for tension-type headache, 12.1% (95% CI, 10.6 to 13.6). Migraine and tension-type headache were significantly associated.
CONCLUSIONS: It is concluded that exposition of subjects to sunlight, type of food, and a family history of headache had most significant effects on occurrence of migraine and tension-type headaches.

Entities:  

Mesh:

Year:  2002        PMID: 12010386     DOI: 10.1046/j.1526-4610.2002.02082.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

1.  Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010.

Authors:  Saeed Shahbeigi; Seyed-Mohammad Fereshtehnejad; Navid Mohammadi; Mohammad Mahdi Golmakani; Sayeh Tadayyon; Ghazal Jalilzadeh; Hossein Pakdaman
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

Review 2.  Tension-type headache in children and adolescents.

Authors:  Pirjo Anttila
Journal:  Curr Pain Headache Rep       Date:  2004-12

3.  New MRI Finding in Migraineurs: Mesial Temporal Sclerosis.

Authors:  Bagheri M H; Jalli R; Hoseyni Moghadam A
Journal:  J Biomed Phys Eng       Date:  2020-08-01

Review 4.  Epidemiology of migraine and headache in children and adolescents.

Authors:  Ciçek Wöber-Bingöl
Journal:  Curr Pain Headache Rep       Date:  2013-06

Review 5.  Migraine at all ages.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2006-06

6.  Alexithymia in juvenile primary headache sufferers: a pilot study.

Authors:  Michela Gatta; Elisabetta Canetta; Maria Zordan; Andrea Spoto; Emilia Ferruzza; Irene Manco; Alessandra Addis; Lara Dal Zotto; Irene Toldo; Stefano Sartori; Pier Antonio Battistella
Journal:  J Headache Pain       Date:  2010-08-22       Impact factor: 7.277

7.  Prevalence of migraine and tension-type headache among school children in Yazd, Iran.

Authors:  H Fallahzadeh; M Alihaydari
Journal:  J Pediatr Neurosci       Date:  2011-07

8.  Etiopathophysiological assessment of cases with chronic daily headache: A functional magnetic resonance imaging included investigation.

Authors:  Akram Hashemi; Mohammad Torabi Nami; Mohammad Ali Oghabian; Habib Ganjgahi; Zahra Vahabi; Hajir Sikaroodi
Journal:  Iran J Neurol       Date:  2012

9.  Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations.

Authors:  Timothy J Steiner; Lars Jacob Stovner; Mohammed Al Jumah; Gretchen L Birbeck; Gopalakrishna Gururaj; Rigmor Jensen; Zaza Katsarava; Luiz Paulo Queiroz; Ann I Scher; Redda Tekle-Haimanot; Shuu-Jiun Wang; Paolo Martelletti; Tarun Dua; Somnath Chatterji
Journal:  J Headache Pain       Date:  2013-10-25       Impact factor: 7.277

Review 10.  The Prevalence of Migraine in Iran: A Systematic Review and Meta-Analysis.

Authors:  Zeynab Farhadi; Saeideh Alidoost; Meysam Behzadifar; Roghayeh Mohammadibakhsh; Najmeh Khodadadi; Razieh Sepehrian; Rahim Sohrabi; Masood Taheri Mirghaed; Morteza Salemi; Hamid Ravaghi; Masoud Behzadifar
Journal:  Iran Red Crescent Med J       Date:  2016-09-21       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.